Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Single Center, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris
Authors not listed
Amir Moradi MD, MBA · 2020
Abstract
Single Center, Double Blind, Placebo- Controlled Study of 20 subjects with 10 active drug/10 placebo
Standardized baseline/pre-treatments and follow-up images will be taken.
Subjects will receive injection of either study drug or placebo to the Depressor Anguli Oris. Follow ups will occur at 2 weeks, 4 weeks, and 12 weeks.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-08 MST
Cite this
APA
Anonymous. (2020). A Single Center, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris. <em>Amir Moradi MD, MBA</em>. https://clinicaltrials.gov/study/NCT04240535
Vancouver
Anonymous. A Single Center, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris. Amir Moradi MD, MBA. 2020.
BibTeX
@misc{anon2020ASingl,
title = {A Single Center, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of OnabotulinumtoxinA to the Depressor Anguli Oris},
author = {Anonymous},
journal = {Amir Moradi MD, MBA},
year = {2020},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Pfizer 2009
Open access · US-GOV
A 52-Week, Two-Period, Multicenter, Randomized, Double-Blind, Donepezil-Referenced, Placebo-Controlled, Efficacy And Safety Study Of 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease
Actinogen Medical 2019
Open access · US-GOV
XanaHES: A Phase I, Single Blinded, Central Reader Blinded, Placebo-Controlled, Dose Escalation Study of Xanamem™ to Assess Safety and Tolerability in Healthy Elderly Subjects
University of California, San Diego 2008
Open access · US-GOV
Coenzyme Q10 and Aging: A Planning Grant
Magellan Stem Cells 2025
Open access · US-GOV
A Phase 3, Multicentre, Randomised, Double Blind, Placebo-controlled Study to Evaluate the Effectiveness, Safety, and Tolerability of MAG200 (an Allogeneic Adipose-derived Mesenchymal Stem Cell Preparation) Administered by Intra-articular Injection to Adult Participants With Symptomatic Osteoarthritis of the Knee.
Clasado Limited 2016
Open access · US-GOV
A Double Blind, Placebo Controlled, Randomised, Single Centred, Parallel Study to Determine the Potential of B-GOS, to Beneficially Influence the Wellbeing and Ageing in Healthy 52-65 Years Old Individuals
Jiangsu T-Mab Biopharma Co.,Ltd 2017
Open access · US-GOV